Directory
>
Jeremy Bender
Jeremy Bender
Independent Board Member | Day One Biopharmaceuticals
Burlingame, California, United States
Jeremy Bender
Summary
Jeremy Bender is a seasoned executive in the life sciences sector, currently serving as the CEO of Day One Biopharmaceuticals. With a robust background in corporate development and strategic planning, he has demonstrated expertise in navigating complex business landscapes within the biopharmaceutical and biotechnology industries. His career includes significant roles at leading organizations such as Gilead Sciences and Tizona Therapeutics, where he honed his skills in mergers and acquisitions, business development, and commercialization strategies. Jeremy holds an MBA from MIT's Sloan School of Management and a Ph.D. in Microbiology and Immunology from the University of Colorado. His leadership style is characterized by a strong focus on innovation and collaboration, driving teams toward achieving ambitious goals. Outside of his executive roles, he contributes to the industry as an independent board member, showcasing his commitment to fostering growth in emerging biopharma ventures.
Jeremy Bender
Work Experience
Independent Board Member at
MEREO BIOPHARMA GROUP PLC
October 2020 - Present
Chief Executive Officer at
Day One Biopharmaceuticals
September 2020 - Present
Vice President Corporate Development at
Gilead Sciences Austria
March 2018 - September 2020
Chief Operating Officer at
Medspa Miami, P.A.
July 2015 - March 2018
Chief Business Officer at
Sutro Biopharma, Inc.
October 2012 - July 2015
Member of the Board of Directors at
Vaxcyte
September 2013 - July 2015
Vice President, Corporate Development at
Allos Therapeutics
January 2006 - September 2012
Project Leader, Consultant at
THE BOSTON CONSULTING GROUP HOLDING (THAILAND) LIMITED
January 2003 - January 2006
Jeremy Bender
Education
Massachusetts Institute of Technology - Sloan School of Management, Mba
January 2000 - January 2002
University of Colorado Anschutz Medical Campus, Ph.D.
January 1994 - January 2000
Stanford University, B.S.
January 1989 - January 1993
Frequently Asked Questions about Jeremy Bender
What is Jeremy Bender email address?
Jeremy Bender's primary email address is *************@dayonebio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jeremy Bender work for?
Jeremy Bender is a Independent Board Member at Day One Biopharmaceuticals, a company specializing in Commercial physical research.
Where Jeremy Bender graduated from?
Jeremy Bender holds a degree in from Massachusetts Institute of Technology - Sloan School of Management.
How can I directly contact Jeremy Bender?
To contact Jeremy Bender directly, you can use the email address *************@dayonebio.com. Complete contact information is available upon registration with Muraena.
Who is Jeremy Bender?
Jeremy Bender is a seasoned executive in the life sciences sector, currently serving as the CEO of Day One Biopharmaceuticals. With a robust background in corporate development and strategic planning, he has demonstrated expertise in navigating complex business landscapes within the biopharmaceutical and biotechnology industries. His career includes significant roles at leading organizations such as Gilead Sciences and Tizona Therapeutics, where he honed his skills in mergers and acquisitions, business development, and commercialization strategies. Jeremy holds an MBA from MIT's Sloan School of Management and a Ph.D. in Microbiology and Immunology from the University of Colorado. His leadership style is characterized by a strong focus on innovation and collaboration, driving teams toward achieving ambitious goals. Outside of his executive roles, he contributes to the industry as an independent board member, showcasing his commitment to fostering growth in emerging biopharma ventures.
Jeremy`s contact details
*************@dayonebio.com
*************@mereobiopharma.com
Colleagues
Vice President, Talent
Vice President of Sales
Vice President, Market Access and HEOR Strategy
VP, Associate General Counsel
Senior Vice President of Corporate Development
Vice President, CMC
Vice President, Development Operations
VP, Translational Sciences
VP & Head of Clinical Pharmacology
Chief Medical Officer